John Vines - Scotts Miracle Lead Independent Director
| SMG Stock | USD 67.70 0.11 0.16% |
Director
Lt. Gen. John Randolph Vines is Lead Independent Director of the Company. Lieutenant General Vines has operated John R. Vines Associates LLC, a strategic provider of business consulting services, since 2007. General Vines also has served as a Senior Advisor to McChrystal Group since 2011, as well as a senior consultant to multiple Fortune 500 companies. General Vines retired in 2007 from the U.S. Army after 35 years active service. He was in continuous command for his last six years of service, including Commander, U.S. Armys XVIII Airborne Corporationration and MultiNational Corporationration Iraq. In addition, he commanded the Combined Joint Task Force 180 Afghanistan. General Vines also served as the Senior Defense Representative to Afghanistan and Pakistan and previously commanded the 82nd Airborne Division, which included a yearlong deployment in Afghanistan. Following retirement, General Vines has acted as a Department of Defense Senior Mentor to U.S. Army and joint senior leadership and deploying combat units, a member of the Defense Service Board and a member of the Army DARPA Senior Advisory Group. since 2014.
| Age | 71 |
| Tenure | 10 years |
| Professional Marks | MBA |
| Address | 14111 Scottslawn Road, Marysville, OH, United States, 43041 |
| Phone | 937 644 0011 |
| Web | https://scottsmiraclegro.com |
John Vines Latest Insider Activity
Tracking and analyzing the buying and selling activities of John Vines against Scotts Miracle stock is an integral part of due diligence when investing in Scotts Miracle. John Vines insider activity provides valuable insight into whether Scotts Miracle is net buyers or sellers over its current business cycle. Note, Scotts Miracle insiders must abide by specific rules, including filing SEC forms every time they buy or sell Scotts Miracle'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
John Vines over two months ago Exercise or conversion by John Vines of tradable shares of Scotts Miracle subject to Rule 16b-3 | ||
John Vines over three months ago Acquisition by John Vines of tradable shares of Scotts Miracle subject to Rule 16b-3 | ||
John Vines over six months ago Exercise or conversion by John Vines of tradable shares of Scotts Miracle subject to Rule 16b-3 | ||
John Vines over six months ago Acquisition by John Vines of tradable shares of Scotts Miracle subject to Rule 16b-3 |
Scotts Miracle Management Efficiency
The company has Return on Asset of 0.0398 % which means that on every $100 spent on assets, it made $0.0398 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.4764) %, meaning that it generated no profit with money invested by stockholders. Scotts Miracle's management efficiency ratios could be used to measure how well Scotts Miracle manages its routine affairs as well as how well it operates its assets and liabilities. The Scotts Miracle's current Return On Equity is estimated to increase to 1.72, while Return On Tangible Assets are forecasted to increase to (0.12). At this time, Scotts Miracle's Intangible Assets are most likely to increase significantly in the upcoming years. The Scotts Miracle's current Other Assets is estimated to increase to about 764.5 M, while Non Current Assets Total are projected to decrease to roughly 1.3 B.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Yaacov Dior | ICL Israel Chemicals | 71 | |
| Nadav Kaplan | ICL Israel Chemicals | 74 | |
| Barth Whitham | Intrepid Potash | 64 | |
| Sagi Kabla | ICL Israel Chemicals | 44 | |
| Avisar Paz | ICL Israel Chemicals | 64 | |
| Lior Reitblatt | ICL Israel Chemicals | 63 | |
| Aviad Kaufman | ICL Israel Chemicals | 50 | |
| Miriam Haran | ICL Israel Chemicals | 71 | |
| Ruth Ralbag | ICL Israel Chemicals | 59 | |
| Ron Moskovitz | ICL Israel Chemicals | 52 | |
| Eran Sarig | ICL Israel Chemicals | 40 | |
| Shimon Eckhaus | ICL Israel Chemicals | 65 | |
| J Martin | Intrepid Potash | 73 | |
| Geoffery Merszei | ICL Israel Chemicals | 61 | |
| Ovadia Eli | ICL Israel Chemicals | 75 | |
| Terry Considine | Intrepid Potash | 73 | |
| Chris Elliott | Intrepid Potash | 55 | |
| Reem Aminoach | ICL Israel Chemicals | 59 | |
| Landis Martin | Intrepid Potash | 72 | |
Management Performance
| Return On Equity | -0.48 | |||
| Return On Asset | 0.0398 |
Scotts Miracle Gro Leadership Team
Elected by the shareholders, the Scotts Miracle's board of directors comprises two types of representatives: Scotts Miracle inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Scotts. The board's role is to monitor Scotts Miracle's management team and ensure that shareholders' interests are well served. Scotts Miracle's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Scotts Miracle's outside directors are responsible for providing unbiased perspectives on the board's policies.
| James Hagedorn, Chairman of the Board, Chief Executive Officer | ||
| Brian Finn, Independent Director | ||
| Ivan Esq, Gen VP | ||
| Christopher Hagedorn, Division President | ||
| Craig Hargreaves, Director | ||
| Dave Swihart, Senior Development | ||
| Matthew Garth, Ex CFO | ||
| Nancy Mistretta, Independent Director | ||
| Thomas Coleman, Chief Financial Officer, Executive Vice President | ||
| Scott Hendrick, Senior Chain | ||
| Michael Lukemire, President, Chief Operating Officer | ||
| Cory Miller, Interim Chief Financial Officer, Senior Vice President | ||
| Dimiter Todorov, General EVP | ||
| Julie DeMuesy, Chief VP | ||
| Thomas Kelly, Independent Director | ||
| Michelle Johnson, Director | ||
| James McCann, Independent Director | ||
| John Vines, Lead Independent Director | ||
| Ivan Smith, Executive Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary | ||
| Adam Hanft, Independent Director | ||
| Aimee DeLuca, Senior Relations | ||
| Stephen Johnson, Independent Director | ||
| Phil Jones, Senior Sales | ||
| Nathan Baxter, Executive COO | ||
| David Evans, Independent Director | ||
| Josh Peoples, VP Officer | ||
| Denise Stump, Executive Vice President - Global Human Resources, Chief Ethics Officer | ||
| Katherine Littlefield, Director | ||
| Gerald Volas, Independent Director | ||
| James King, Executive Vice President Chief Communications Officer | ||
| Peter Shumlin, Independent Director |
Scotts Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Scotts Miracle a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.48 | |||
| Return On Asset | 0.0398 | |||
| Profit Margin | (0.12) % | |||
| Operating Margin | (0.14) % | |||
| Current Valuation | 7.21 B | |||
| Shares Outstanding | 56.69 M | |||
| Shares Owned By Insiders | 25.39 % | |||
| Shares Owned By Institutions | 77.48 % | |||
| Number Of Shares Shorted | 4.48 M | |||
| Price To Earning | 6.67 X |
Currently Active Assets on Macroaxis
When determining whether Scotts Miracle Gro is a strong investment it is important to analyze Scotts Miracle's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Scotts Miracle's future performance. For an informed investment choice regarding Scotts Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Scotts Miracle Gro. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Complementary Tools for Scotts Stock analysis
When running Scotts Miracle's price analysis, check to measure Scotts Miracle's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scotts Miracle is operating at the current time. Most of Scotts Miracle's value examination focuses on studying past and present price action to predict the probability of Scotts Miracle's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scotts Miracle's price. Additionally, you may evaluate how the addition of Scotts Miracle to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| CEOs Directory Screen CEOs from public companies around the world |
Is Scotts Miracle's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Scotts Miracle. If investors know Scotts will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Scotts Miracle listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.61) | Dividend Share 2.64 | Earnings Share (7.04) | Revenue Per Share 61.014 | Quarterly Revenue Growth (0.22) |
The market value of Scotts Miracle Gro is measured differently than its book value, which is the value of Scotts that is recorded on the company's balance sheet. Investors also form their own opinion of Scotts Miracle's value that differs from its market value or its book value, called intrinsic value, which is Scotts Miracle's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Scotts Miracle's market value can be influenced by many factors that don't directly affect Scotts Miracle's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Scotts Miracle's value and its price as these two are different measures arrived at by different means. Investors typically determine if Scotts Miracle is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Scotts Miracle's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.